FDA cleared the Lumify Diagnostic Ultrasound System from Philips Ultrasound, LLC on May 5, 2026 under K252558, a traditional 510(k). The device falls under product code IYN, System, Imaging, Pulsed Doppler, Ultrasonic, regulated at 21 CFR 892.1550 as a Class 2 device. The review panel was Radiology.

FDA logged the submission as received on Aug 13, 2025. The decision came 265 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

Philips Ultrasound, LLC has 8 other decisions in the tracker over the last 12 months: K262311 (Alturion Series Diagnostic Ultrasound System), K261211 (Philips EPIQ Series Diagnostic Ultrasound System; Philips Affiniti Series Diagnostic Ultrasound System), K260667 (Alturion Series Diagnostic Ultrasound System), K260123 (EPIQ Series Diagnostic Ultrasound System).